Abstract
Estrogen-related receptors alpha (ERRalpha) and peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) function coordinately to regulate mitochondrial biogenesis and oxidative phosphorylation particularly in muscle tissue. In this study, we addressed the consequences of suppressing the activity of ERRalpha in L6 myotubes using an ERRalpha inverse agonist XCT-790. We found that treating differentiated L6 myotubes with XCT-790 reduced the expression of PGC-1alpha and suppressed mitochondrial biogenesis. Additionally, XCT-790 increased the production of reactive oxygen species (ROS) which in turn induced the expressions of glucose transporters 1, 2, and 5 leading to an increase in glucose uptake and uncoupling protein 3 leading to a reduction of mitochondrial membrane potential. Thus, suppressing the activity of ERRalpha which is primarily responsible for controlling beta-oxidation would nonetheless indirectly affect glucose uptake in a ROS-dependent manner.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
